» Articles » PMID: 38892937

New Method of Papillectomy May Decrease Recurrence: Anchoring Method Versus Conventional Method

Overview
Journal J Clin Med
Specialty General Medicine
Date 2024 Jun 19
PMID 38892937
Authors
Affiliations
Soon will be listed here.
Abstract

: Endoscopic papillectomy (EP) is the preferred treatment for ampullary tumors because it has fewer side effects than surgical removal. This study retrospectively compared a new anchoring EP method (A-EP) with the conventional (C-EP) approach. : Ninety-nine patients who underwent EP at a single medical institution between 2009 and 2021 were retrospectively reviewed. In all patients, the indications for EP were pathological adenoma with <10 mm of biliary invasion and a tumor diameter <30 mm on endoscopic ultrasonography. The exclusion criteria were antiplatelet/anticoagulant use, previous upper GI surgery, or prior biliary/pancreatic endoscopic therapy. One expert endoscopist performed the two types of EPs, A-EP and C-EP. : Sixty-two patients underwent A-EP, and 37 underwent C-EP. There were no significant differences in baseline characteristics, such as sex, age, tumor size, and ductal invasion on endoscopic ultrasound. The A-EP group had higher en bloc resection rates (95.2% vs. 78.4%, = 0.010). Although the difference was not statistically significant, it tended towards fewer incidences of pancreatitis ( = 0.081) and duct stricture ( = 0.081). The recurrence rate was lower in the A-EP group (8.1% vs. 37.8%, = 0.000). There were no significant differences between the two groups regarding the follow-up period (A-EP vs. C-EP, 725 vs. 1045 days, = 0.109) or the days of recurrence (A-EP vs. C-EP, 341 vs. 562 days, = 0.551). : A-EP showed better outcomes than C-EP in terms of en bloc resection and recurrence rates, providing evidence for the efficacy of this novel EP method.

References
1.
Tringali A, Valerii G, Boskoski I, Familiari P, Landi R, Perri V . Endoscopic snare papillectomy for adenoma of the ampulla of vater: Long-term results in 135 consecutive patients. Dig Liver Dis. 2020; 52(9):1033-1038. DOI: 10.1016/j.dld.2020.05.029. View

2.
Lee R, Huelsen A, Gupta S, Hourigan L . Endoscopic ampullectomy for non-invasive ampullary lesions: a single-center 10-year retrospective cohort study. Surg Endosc. 2020; 35(2):684-692. DOI: 10.1007/s00464-020-07433-7. View

3.
Desilets D, Dy R, Ku P, Hanson B, Elton E, Mattia A . Endoscopic management of tumors of the major duodenal papilla: Refined techniques to improve outcome and avoid complications. Gastrointest Endosc. 2001; 54(2):202-8. DOI: 10.1067/mge.2001.116564. View

4.
Rostain F, Hamza S, Drouillard A, Faivre J, Bouvier A, Lepage C . Trends in incidence and management of cancer of the ampulla of Vater. World J Gastroenterol. 2014; 20(29):10144-50. PMC: 4123344. DOI: 10.3748/wjg.v20.i29.10144. View

5.
Irani S, Arai A, Ayub K, Biehl T, Brandabur J, Dorer R . Papillectomy for ampullary neoplasm: results of a single referral center over a 10-year period. Gastrointest Endosc. 2009; 70(5):923-32. DOI: 10.1016/j.gie.2009.04.015. View